Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

CSL acquires majority stake in Chinese plasma manufacturer Ruide for $352mm, plus earn-out

Executive Summary

CSL Ltd. acquired an 80% stake in Humanwell Healthcare's Wuhan Zhong Yuan Rui De Biological Products Co. (Ruide), a manufacturer of plasma-based therapies, for $352mm in cash, which CSL will fund through an existing debt facility.
Deal Industry
  • Pharmaceuticals
  • Services
  • Biotechnology
    • Synthesis Technologies, Production Processes
Deal Status
  • Final
Deal Type
  • Acquisition
    • Acquisition of Private Biotech
    • Includes Earnout
    • Partial Acquisition
    • Payment Includes Cash

Related Companies